Artelo Biosciences, Inc. (ARTL) vs GENPREX (GNPX)
Artelo Biosciences, Inc. and GENPREX are both Biotechnology companies. Artelo Biosciences, Inc. and GENPREX are of similar size ($2.8M and $2.7M). Artelo Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; GENPREX trades at 0.0×. Across the 10 metrics below, GENPREX leads on 7 and Artelo Biosciences, Inc. on 3.
Valuation
Profitability
| Metric | ARTL | GNPX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (705.71%) | (203.86%) | (57.72%) |
| Return on assets | (234.30%) | (157.40%) | (49.22%) |
| Return on invested capital | (865.85%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack